文献速递细菌感染、耐药与抗菌药物医院感染防控

疑似脓毒症患者抗生素降阶梯退出式方案评估:多中心随机对照试验

Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial.
PubMed 文献 · Clin Infect Dis · 2023-01-01

在美国10家医院纳入血培养阴性但仍使用广谱抗生素的非重症成人,随机分为退出式降阶梯方案组与常规治疗组。干预组抗生素继续使用的比值更低(79% vs 84%;OR 0.68;95%CI 0.47-0.98),继续使用者疗程天数相似,30天安全事件相似。

要点

  • 退出式方案使疑似脓毒症患者抗生素继续使用比值降低(79% vs 84%;OR 0.68;95%CI 0.47-0.98)。
  • 继续使用抗生素者中,两组疗程天数相似(均值比1.06;95%CI 0.88-1.26)。
  • 干预组暴露于广谱抗生素者更少(36% vs 44%),30天安全事件相似。

核心结论

  • 针对疑似脓毒症患者的抗生素退出式方案使更多患者停用抗生素,继续使用抗生素时疗程天数相似,且无伤害证据。

研究设计与样本

  • 多中心随机对照试验,2018年9月至2020年5月在美国10家医院纳入血培养阴性但仍使用广谱抗生素的非重症成人。
  • 筛查9606例,纳入767例(8%),随机分为退出式方案组与常规治疗组。
  • 23项安全检查排除了有持续全身感染征象、微生物学数据令人担忧或不充分、或高危情况的患者。
  • 主要结局为入组后抗菌药物疗程天数(DOT)。

主要发现

  • 干预组抗生素继续使用的比值更低(79% vs 84%;OR 0.68;95%CI 0.47-0.98)。
  • 继续使用抗生素者中,两组DOT均值比1.06(95%CI 0.88-1.26)。
  • 干预组暴露于广谱抗生素者更少(36% vs 44%)。
  • 继续使用抗生素的常见原因为治疗局部感染(76%)和认为停用抗生素不安全(31%)。
  • 30天安全事件相似。

关键数值与推荐

  • 纳入标准:非重症成人,血培养阴性但仍使用广谱抗生素。
  • 排除标准:23项安全检查提示持续全身感染征象、微生物学数据令人担忧或不充分、或高危情况。

临床怎么用

  • 对符合安全检查的疑似脓毒症患者,采用退出式沟通语言鼓励停用抗生素。
  • 若临床医生选择继续抗生素,则讨论继续使用的理由及降阶梯计划。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sepsis guidelines recommend daily review to de-escalate or stop antibiotics in appropriate patients. This randomized, controlled trial evaluated an opt-out protocol to decrease unnecessary antibiotics in patients with suspected sepsis. METHODS: We evaluated non-intensive care adults on broad-spectrum antibiotics despite negative blood cultures at 10 US hospitals from September 2018 through May 2020. A 23-item safety check excluded patients with ongoing signs of systemic infection, concerning or inadequate microbiologic data, or high-risk conditions. Eligible patients were randomized to the opt-out protocol vs usual care. Primary outcome was post-enrollment antibacterial days of therapy (DOT). Clinicians caring for intervention patients were contacted to encourage antibiotic discontinuation using opt-out language. If continued, clinicians discussed the rationale for continuing antibiotics and de-escalation plans. To evaluate those with zero post-enrollment DOT, hurdle models provided 2 measures: odds ratio of antibiotic continuation and ratio of mean DOT among those who continued antibiotics. RESULTS: Among 9606 patients screened, 767 (8%) were enrolled. Intervention patients had 32% lower odds of antibiotic continuation (79% vs 84%; odds ratio, 0.68; 95% confidence interval [CI], .47-.98). DOT among those who continued antibiotics were similar (ratio of means, 1.06; 95% CI, .88-1.26). Fewer intervention patients were exposed to extended-spectrum antibiotics (36% vs 44%). Common reasons for continuing antibiotics were treatment of localized infection (76%) and belief that stopping antibiotics was unsafe (31%). Thirty-day safety events were similar. CONCLUSIONS: An antibiotic opt-out protocol that targeted patients with suspected sepsis resulted in more antibiotic discontinuations, similar DOT when antibiotics were continued, and no evidence of harm. CLINICAL TRIALS REGISTRATION: NCT03517007.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Moehring RW, Yarrington ME, Warren BG, et al. Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial. Clin Infect Dis. 2023. PMID: 36167851. doi:10.1093/cid/ciac787

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。